MedTech Dive December 4, 2023
After gaining market share during the Philips recall, Resmed can keep growing by stimulating demand through marketing initiatives and new products, William Blair analysts wrote.
Dive Brief:
- The leadership shakeup at Resmed could help the company meet and beat its growth targets by growing demand for its sleep apnea devices, according to William Blair analysts.
- CEO Mick Farrell and other Resmed executives spoke to the analysts last week in meetings that left the William Blair team “more positive on the company’s strategy and ability to grow above market growth on the top line.”
- The optimism is underpinned by a belief that Resmed, having increased its market share during the Philips recall, can continue to grow by mounting its...